Waist circumference adjusted for body mass index and intra-abdominal fat mass

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Berentzen, Tina Landsvig ^a   Ängquist, Lars ^a   Kotronen, Anna ^b,c   Borra, Ronald ^d   Yki Järvinen, Hannele ^b   Iozzo, Patricia ^d,e   Parkkola, Riitta ^d   Nuutila, Pirjo ^d   Ross, Robert ^f   Allison, David B ^g   Heymsfield, Steven B ^h   Overvad, Kim ^i,j   Sørensen, Thorkild I A ^a   Jakobsen, Marianne Uhre ⁱ  

^a The Capital Region   (Denmark)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^f QUEEN S UNIVERSITY   (Canada)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

ⁱ AARHUS UNIVERSITY   (Denmark)

^j AALBORG UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SUBCUTANEOUS FAT MASS; ADULT; ARTICLE; BODY MASS; CANADA; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; INTRAABDOMINAL FAT; INTRAABDOMINAL FAT MASS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; WAIST CIRCUMFERENCE; AGED; BODY COMPOSITION; GLUCOSE TOLERANCE TEST; METHODOLOGY; MIDDLE AGED; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INTRA-ABDOMINAL FAT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; WAIST CIRCUMFERENCE;

EID: 84857537933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032213     Document Type: Article

References (30)

1. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, et al. (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359: 2105-2120.
2. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096.
3. Berrington de GA, Hartge P, Cerhan JR, Flint AJ, Hannan L, et al. (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363: 2211-2219 10.1056/NEJMoa1000367 [doi].
4. Bigaard J, Tjonneland A, Thomsen BL, Overvad K, Heitmann BL, et al. (2003) Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res 11: 895-903.
5. Janssen I, Katzmarzyk PT, Ross R, (2005) Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 53: 2112-2118.
6. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, et al. (2003) Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol 158: 1161-1170.
7. Zhang C, Rexrode KM, Van Dam RM, Li TY, Hu FB, (2008) Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117: 1658-1667.
8. Jacobs EJ, Newton CC, Wang Y, Patel AV, McCullough ML, et al. (2010) Waist Circumference and All-Cause Mortality in a Large US Cohort. Arch Intern Med 170: 1293-1301.
9. Arner P, (1998) Not all fat is alike. Lancet 351: 1301-1302.
10. Bjorntorp P, (1997) Obesity. Lancet 350: 423-426.
11. Lautamaki R, Borra R, Iozzo P, Komu M, Lehtimaki T, et al. (2006) Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 291: E282-E290 00604.2005 [pii];10.1152/ajpendo.00604.2005 [doi].
12. Lee S, Hudson R, Kilpatrick K, Graham TE, Ross R, (2005) Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 28: 566-572 28/3/566 [pii].
13. Davidson LE, Hudson R, Kilpatrick K, Kuk JL, McMillan K, et al. (2009) Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. Arch Intern Med 169: 122-131.
14. Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, et al. (2004) Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 12: 789-798.
15. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, et al. (2000) Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133: 92-103.
16. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, et al. (2009) Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137: 865-872 S0016-5085(09)00913-5 [pii];10.1053/j.gastro.2009.06.005 [doi].
17. Borra R, Lautamaki R, Parkkola R, Komu M, Sijens PE, et al. (2008) Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. Metabolism 57: 1445-1451 S0026-0495(08)00201-1 [pii];10.1016/j.metabol.2008.05.015 [doi].
18. Bucci M, Borra R, Nagren K, Parkka JP, Del RS, et al. (2011) Trimetazidine Reduces Endogenous Free Fatty Acid Oxidation and Improves Myocardial Efficiency in Obese Humans. Cardiovasc Ther 10.1111/j.1755-5922.2011.00275.x [doi].
19. Viljanen AP, Iozzo P, Borra R, Kankaanpaa M, Karmi A, et al. (2009) Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J Clin Endocrinol Metab 94: 50-55 jc.2008-1689 [pii];10.1210/jc.2008-1689 [doi].
20. Virtanen KA, Hallsten K, Parkkola R, Janatuinen T, Lonnqvist F, et al. (2003) Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes 52: 283-290.
21. Ross R, Rissanen J, Pedwell H, Clifford J, Shragge P, (1996) Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J Appl Physiol 81: 2445-2455.
22. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H, (2007) Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 92: 3490-3497.
23. Abate N, Garg A, Coleman R, Grundy SM, Peshock RM, (1997) Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr 65: 403-408.
24. Draper N, Smith H, (1981) Applied Regression Analysis Wiley.
25. Bosy-Westphal A, Booke CA, Blocker T, Kossel E, Goele K, et al. (2010) Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J Nutr 140: 954-961 jn.109.118737 [pii];10.3945/jn.109.118737 [doi].
26. Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, et al. (2008) Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes Rev 9: 312-325.
27. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R, (2002) Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 75: 683-688.
28. Heitmann BL, Lissner L, (2010) Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality. Obes Rev.
29. Bigaard J, Frederiksen K, Tjonneland A, Thomsen BL, Overvad K, et al. (2004) Waist and hip circumferences and all-cause mortality: usefulness of the waist-to-hip ratio? Int J Obes Relat Metab Disord 28: 741-747.
30. Manolopoulos KN, Karpe F, Frayn KN, (2010) Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34: 949-959.